← Back to Patent Explorer
US4650909A Expired / Lapsed US ⏱️ 0.0 years remaining

Polyethylene glycol (PEG) reagent

Assignee: Individual
•
Filing: 1985-10-29
•
Granted: 1987-03-17
•
Expires: 2005-10-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for production of improved polyethylene glycol (PEG) is disclosed. This process overcomes the toxicity that results from using the known (and impure) PEG-fusion reagent by incorporation of a purification method that removes the toxic elements always present in PEG preparations stored above 0° C. in the presence of oxygen.

Inventors

  • 👤 George H. Yoakum

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 23:10
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/10; C12N5/12; C12N5/16; C08; C08G; C08G65/00; C08G65/02; C08G65/30; C08L; C08L71/00; C08L71/02

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 87 words
A process for the production of polyethylene glycol (PEG) molecular weight, 1000-6000 for human cell genetic transfection comprising melting PEG; adding a resin to said PEG to form a PEG/resin slurry at a pH of about 7.4, said resin consisting of cationic and anionic resins selected from the group consisting of a mixed bed resin containing a styrene-divinyl benzene backbone, a cross-linked dextran containing a diethyl (2-hydroxypropyl)amino ethyl functional group, and mixtures thereof; filtering the PEG/resin slurry through fresh mixed bed resin to obtain the improved PEG.
Claim 2
Dependent Claim 87 words
A process for the production of polyethylene glycol (PEG) molecular weight, 1000-6000 for human cell genetic transfection comprising melting PEG; adding a resin to said PEG to form a PEG/resin slurry at a pH of about 7.4, said resin consisting of cationic and anionic resins selected from the group consisting of a mixed bed resin containing a styrene-divinyl benzene backbone, a cross-linked dextran containing a diethyl (2-hydroxypropyl)amino ethyl functional group, and mixtures thereof; filtering the PEG/resin slurry through fresh mixed bed resin to obtain the improved PEG.
Claim 3
Dependent Claim 25 words
The process of claim 1 wherein the resin is said mixed bed divinylbenzene resin in combination with said dextran resin with an amino functional group.
Claim 4
Dependent Claim 21 words
The process in claim 1 wherein said improved PEG is 1000 molecular weight and a melting point of about 42° C.
Claim 5
Dependent Claim 87 words
A fusion grade reagent suitable for use in human cell fusion produced by the process comprising melting polyethylene glycol (PEG) molecular weight, 1000-6000 adding a resin to form a PEG/resin slurry at a pH of about 7.4, said resin consisting of cationic and anionic resins selected from the group consisting of a mixed bed resin containing a styrene-divinyl benzene backbone, a cross-linked dextran containing a diethyl (2-hydroxypropyl)-amino ethyl functional group, and mixtures thereof; filtering the PEG/resin slurry through fresh mixed bed resin to obtain the improved PEG.
Claim 6
Dependent Claim 87 words
A fusion grade reagent suitable for use in human cell fusion produced by the process comprising melting polyethylene glycol (PEG) molecular weight, 1000-6000 adding a resin to form a PEG/resin slurry at a pH of about 7.4, said resin consisting of cationic and anionic resins selected from the group consisting of a mixed bed resin containing a styrene-divinyl benzene backbone, a cross-linked dextran containing a diethyl (2-hydroxypropyl)-amino ethyl functional group, and mixtures thereof; filtering the PEG/resin slurry through fresh mixed bed resin to obtain the improved PEG.
Claim 7
Dependent Claim 27 words
The fusion grade reagent in claim 4 wherein said resin is said mixed bed divinylbenzene resin in combination with said dextran resin with an amino functional group.
Claim 8
Dependent Claim 24 words
The reagent of claim 4 wherein said fusion grade reagent is 1000 molecular weight polyethylene glycol with a melting point of about 42° C.

References Cited (Backward Citations)

US2812360A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-03-16 1990-09-15 1991-03-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-03-16 1994-09-15 1995-03-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-03-16 1998-09-15 1999-03-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag